These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 12774155)

  • 1. Is low monocyte HLA-DR expression helpful to predict outcome in severe sepsis?
    Perry SE; Mostafa SM; Wenstone R; Shenkin A; McLaughlin PJ
    Intensive Care Med; 2003 Aug; 29(8):1245-52. PubMed ID: 12774155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low plasma granulocyte-macrophage colony stimulating factor is an indicator of poor prognosis in sepsis.
    Perry SE; Mostafa SM; Wenstone R; McLaughlin PJ
    Intensive Care Med; 2002 Jul; 28(7):981-4. PubMed ID: 12122541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of granulocyte-macrophage colony-stimulating factor on the immune response of circulating monocytes after severe trauma.
    Flohé S; Lendemans S; Selbach C; Waydhas C; Ackermann M; Schade FU; Kreuzfelder E
    Crit Care Med; 2003 Oct; 31(10):2462-9. PubMed ID: 14530752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo effect of rhGM-CSF And rhG-CSF on monocyte HLA-DR expression of septic neonates.
    Drossou-Agakidou V; Kanakoudi-Tsakalidou F; Sarafidis K; Tzimouli V; Taparkou A; Kremenopoulos G; Germenis A
    Cytokine; 2002 Jun; 18(5):260-5. PubMed ID: 12161101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-modulation of granulocyte macrophage-colony stimulating factor receptor on monocytes during human septic shock.
    Pangault C; Le Tulzo Y; Tattevin P; Guilloux V; Bescher N; Drénou B
    Crit Care Med; 2006 Apr; 34(4):1193-201. PubMed ID: 16484916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome of critically ill patients cannot be defined by cutoff values of monocyte human leukocyte antigen-DR expression.
    Trimmel H; Luschin U; Köhrer K; Anzur C; Vevera D; Spittler A
    Shock; 2012 Feb; 37(2):140-4. PubMed ID: 22089188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial.
    Meisel C; Schefold JC; Pschowski R; Baumann T; Hetzger K; Gregor J; Weber-Carstens S; Hasper D; Keh D; Zuckermann H; Reinke P; Volk HD
    Am J Respir Crit Care Med; 2009 Oct; 180(7):640-8. PubMed ID: 19590022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocyte HLA-DR expression as predictor of poor outcome in neonates with late onset neonatal sepsis.
    Genel F; Atlihan F; Ozsu E; Ozbek E
    J Infect; 2010 Mar; 60(3):224-8. PubMed ID: 20025903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
    Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human leukocyte antigen-DR expression on peripheral monocytes may be an early marker for secondary infection in severe acute pancreatitis.
    Lin ZQ; Guo J; Xia Q; Yang XN; Huang W; Huang ZW; Xue P
    Hepatogastroenterology; 2013; 60(128):1896-902. PubMed ID: 24719924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis.
    Nierhaus A; Montag B; Timmler N; Frings DP; Gutensohn K; Jung R; Schneider CG; Pothmann W; Brassel AK; Schulte Am Esch J
    Intensive Care Med; 2003 Apr; 29(4):646-51. PubMed ID: 12595977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on monocyte HLA-DR expression in critically ill patients after surgery].
    Zhang YT; Fang Q
    Zhonghua Wai Ke Za Zhi; 2006 Nov; 44(21):1480-2. PubMed ID: 17349175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte-macrophage colony-stimulating factor (GM-CSF) restores decreased monocyte HLA-DR expression after cardiopulmonary bypass.
    Börgermann J; Friedrich I; Scheubel R; Kuss O; Lendemans S; Silber RE; Kreuzfelder E; Flohé S
    Thorac Cardiovasc Surg; 2007 Feb; 55(1):24-31. PubMed ID: 17285470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunological monitoring of sepsis using flow cytometry--quantitation of monocyte HLA-DR expression and granulocyte CD64 expression].
    Sedlácková L; Průcha M; Dostál M
    Epidemiol Mikrobiol Imunol; 2005 Apr; 54(2):54-61. PubMed ID: 16050543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of monocyte human leukocyte antigen-DR expression and stimulated tumor necrosis factor alpha production as outcome predictors in severe sepsis: a prospective observational study.
    Drewry AM; Ablordeppey EA; Murray ET; Beiter ER; Walton AH; Hall MW; Hotchkiss RS
    Crit Care; 2016 Oct; 20(1):334. PubMed ID: 27760554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical trial to verify the value of the CD14(+) monocyte human leukocyte antigen DR as a marker in evaluating immunosuppression in patients with severe sepsis].
    Lin HY; Guo XS; Yao YM; Cheng WX; Weng ZH; Wei WT; Sheng ZY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Mar; 15(3):135-8. PubMed ID: 12831612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human leucocyte antigen (HLA-DR) gene expression is reduced in sepsis and correlates with impaired TNFα response: A diagnostic tool for immunosuppression?
    Winkler MS; Rissiek A; Priefler M; Schwedhelm E; Robbe L; Bauer A; Zahrte C; Zoellner C; Kluge S; Nierhaus A
    PLoS One; 2017; 12(8):e0182427. PubMed ID: 28771573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mononuclear histocompatibility leukocyte antigen-DR expression in the early phase of acute pancreatitis.
    Yu WK; Li WQ; Li N; Li JS
    Pancreatology; 2004; 4(3-4):233-43. PubMed ID: 15166475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical value of monitoring CD14+ monocyte human leukocyte antigen (locus) DR levels in the early stage of sepsis].
    Su L; Zhou DY; Tang YQ; Wen Q; Bai T; Meng FS; Tang LQ; Duan PK
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Nov; 18(11):677-9. PubMed ID: 17092421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DR as a marker for increased risk for systemic inflammation and septic complications after cardiac surgery.
    Oczenski W; Krenn H; Jilch R; Watzka H; Waldenberger F; Köller U; Schwarz S; Fitzgerald RD
    Intensive Care Med; 2003 Aug; 29(8):1253-7. PubMed ID: 12802492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.